New cell therapy shows promise for deadly transplant complication
Disease control
Recruiting now
This study tests an experimental treatment called CYP-001 for people who develop a serious complication called graft-versus-host disease after a stem cell transplant. The treatment is given alongside standard steroids to see if it helps control the disease better than steroids al…
Phase: PHASE2 • Sponsor: Cynata Therapeutics Limited • Aim: Disease control
Last updated May 12, 2026 13:41 UTC